Supplementary Data from MRI and 18FET-PET Predict Survival Benefit from Bevacizumab Plus Radiotherapy in Patients with Isocitrate Dehydrogenase Wild-type Glioblastoma: Results from the Randomized ARTE Trial
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)